The Novel Regimen of Rifapentine, Tedizolid, and Minocycline Is Potent and Could Shorten Therapy Duration for Pulmonary Mycobacterium Kansasii
Year: 2020
Type: conference-abstract
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3041504792
